Michael Ward, DO
Orthopaedic Surgery · Cambridge, MDNPI 1073557153
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 74.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $3,233 and has fallen 98.8% since, to $39 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MD, where the typical reported total is $2,738.
Across 36 payments — averaging $94.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Supreme Orthopedic Systems, LLC$355
- Pacira Therapeutics, Inc.$188
- Johnson & Johnson$96
- Stryker$87
- Foundation Medicine, Inc.$75
- plus $62 from 3 others
What the payments were for
- Travel & lodging$70521%
- Food & beverage$75822%
- Education$1,94957%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 15 | $2,548 |
| Supreme Orthopedic Systems, LLC | 5 | $355 |
| Pacira Therapeutics, Inc. | 4 | $188 |
| Johnson & Johnson | 4 | $96 |
| Stryker | 3 | $87 |
| Foundation Medicine, Inc. | 1 | $75 |
| Smith+Nephew | 2 | $31 |
| KCI USA, Inc. | 1 | $21 |
| Heraeus Medical, LLC. | 1 | $10 |
How this compares
$3,411 in reported general payments places this provider in the 50th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $183 |
| Oxycodone Hcl | 18 | $59 |
| Meloxicam | 15 | $58 |
| Cephalexin | 12 | $53 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Cambridge
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$7.6M
- Anand MurthiBaltimore$3.7M
- Timothy CoddTowson$3.6M
- Khaled KebaishBaltimore$3M
- Michael AinLutherville$1.6M
- Shawn StandardBaltimore$1.4M
- Hamid HassanzadehBethesda$1.1M
- Paul SponsellerBaltimore$958K
- Paul TortolaniTowson$812K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.